PecoraroFDinotoEMirabellaDCorteGBracaleUMBajardiG. Basal cerebral computed tomography as diagnostic tool to improve patient selection in asymptomatic carotid artery stenosis [published online ahead of print January 10, 2012]. Angiology. 2012.
2.
ParaskevasKIMikhailidisDPMooreWSVeithFJ. Optimal contemporary management of symptomatic and asymptomatic carotid artery stenosis. Vascular. 2011;19(3):117–120.
3.
ParaskevasKIMikhailidisDPVeithFJ. Mechanisms to explain the poor results of carotid artery stenting (CAS) in symptomatic patients to date and options to improve CAS outcomes. J Vasc Surg. 2010;52(5):1367–1375.
4.
SchneiderPANaylorAR. Asymptomatic carotid artery stenosis—medical therapy alone versus medical therapy plus carotid endarterectomy or stenting. J Vasc Surg. 2010;52(2):499–507.
5.
RicottaJJAburahmaAAscherEEskandariMFariesPLalBK; Society for Vascular Surgery. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg. 2011;54(3):e1–e31.
6.
Carotid Stenting Guidelines Committee: an Inter-collegiate Committee of the RACP (ANZAN, CSANZ), RACS (ANZSVS) and RANZCR. Guidelines for patient selection and performance of carotid artery stenting. Intern Med J. 2011;41(4):344–347.
7.
GurmHSYadavJSFayadP. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358(15):1572–1579.
8.
BrottTGHobsonRW2ndHowardG; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23.
9.
NaylorARGainesPARothwellPM. Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals?Eur J Vasc Endovasc Surg. 2009;37(6):625–632.
10.
SpenceJDCoatesVLiH. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. 2010;67(2):180–186.
11.
AbbottAL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40(10):e573–e583.
12.
MakrisGCNicolaidesAGeroulakosG. The management of asymptomatic carotid plaque disease: our assumptions when we are less radical. Angiology. 2011;62(6):455–456.
13.
SpenceJDTamayoALownieSPNgWPFergusonGG. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke. 2005;36(11):2373–2378.
14.
ZhangCQuSLiH. Microembolic signals and carotid plaque characteristics in patients with asymptomatic carotid stenosis. Scand Cardiovasc J. 2009;43(5):345–351.
15.
KakkosSKSabetaiMTegosT; Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J Vasc Surg. 2009;49(4):902–909.
16.
NicolaidesANKakkosSKKyriacouE. Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg. 2010;52(6):1486–1496.
17.
KakkosSKNicolaidesANKyriacouE. Computerized texture analysis of carotid plaque ultrasonic images can identify unstable plaques associated with ipsilateral neurological symptoms. Angiology. 2011;62(4):317–328.
18.
MadaniABeletskyVTamayoAMunozCSpenceJD. High-risk asymptomatic carotid stenosis: ulceration on 3D ultrasound vs TCD microemboli. Neurology. 2011;77(8):744–750.
19.
TopakianRKingAKwonSUSchaafsmaAShipleyMMarkusHS;ACESInvestigators. Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis. Neurology. 2011;77(8):751–758.
20.
ParaskevasKIHamiltonGMikhailidisDP. Statins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007;46(2):373–386.
21.
RiccioniGCipolloneFSantovitoD. Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery stenosis. Expert Opin Pharmacother. 2011;12(17):2599–2604.
22.
ParaskevasKILiapisCDHamiltonGMikhailidisDP. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?Eur J Vasc Endovasc Surg. 2006;32(3):286–293.
23.
ParaskevasKIVeithFJLiapisCDMikhailidisDP. Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update [published online ahead of print January 20 2012]. Curr Vasc Pharmacol. 2012.
24.
GröschelKErnemannUSchulzJBNägeleTTerborgCKastrupA. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology. 2006;240(1):145–151.
25.
LiapisCDBellPFMikhailidisDP; ESVS Guidelines Collaborators; European Society for Vascular Surgery. ESVS Guidelines: section A—prevention in patients with carotid stenosis. Curr Vasc Pharmacol. 2010;8(5):673–681.
26.
LiapisCDBellPFMikhailidisDP; ESVS Guidelines Collaborators; European Society for Vascular Surgery. ESVS Guidelines: section B—diagnosis and investigation of patients with carotid stenosis. Curr Vasc Pharmacol. 2010;8(5):682–691.
27.
KadoglouNPSailerNMoumtzouoglouAKapelouzouAGerasimidisTLiapisCD. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. J Vasc Surg. 2010;51(1):114–121.
28.
AmarencoPGoldsteinLBMessigM; SPARCL Investigators. Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke. 2009;40(7):2486–2492.
